Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cisplatin Adverse Reaction”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Large-scale testing (Phase 3)UnknownNCT02250872
What this trial is testing

Effects of DPP4 Inhibitor on Cisplatin Induced Acute Kidney Injury

Who this might be right for
CancerCisplatin Adverse Reaction
Seoul National University Bundang Hospital 182
Not applicableUnknownNCT05247671
What this trial is testing

Evaluation of the Effect of Genetic Polymorphisms in ERCC1 and OCT2 on the Occurrence and Severity of Cisplatin-induced Nephrotoxicity

Who this might be right for
Cisplatin Adverse Reaction
Ain Shams University 89
Large-scale testing (Phase 3)Study completedNCT00017004
What this trial is testing

Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia

Who this might be right for
AnemiaCervical AdenocarcinomaCervical Adenosquamous Carcinoma+6 more
Gynecologic Oncology Group 114
Testing effectiveness (Phase 2)Looking for participantsNCT07169851
What this trial is testing

Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

Who this might be right for
NauseaVomitingDrug-Related Side Effects and Adverse Reactions+1 more
Eli Lilly and Company 204
Post-approval studies (Phase 4)Ended earlyNCT04226456
What this trial is testing

Intratympanic Administration of N-acetylcysteine for Protection of Cisplatin-induced Ototoxicity

Who this might be right for
Ototoxic Hearing LossOtotoxic Hearing Loss, BilateralOtotoxicity+1 more
Centre Hospitalier Universitaire Saint Pierre 19
Testing effectiveness (Phase 2)Looking for participantsNCT07364747
What this trial is testing

Protective Effect of Acetylcysteine Against Cisplatinum-Induced Ototoxicity: A Randomized Controlled Trial

Who this might be right for
Cisplatin-induced OtotoxicitySensorineural Hearing LossOtotoxicity+1 more
Siriraj Hospital 40
Early research (Phase 1)Study completedNCT00003144
What this trial is testing

Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
NYU Langone Health 44
Not applicableStudy completedNCT05789316
What this trial is testing

Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)

Who this might be right for
Head and Neck Cancer SurvivorsCancer of the Head and Neck Surviors
Washington University School of Medicine 55
Testing effectiveness (Phase 2)Study completedNCT06553157
What this trial is testing

Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy

Who this might be right for
Solid TumorsOtotoxicity
Minia University 56
Not applicableNot Yet RecruitingNCT06929468
What this trial is testing

Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer

Who this might be right for
Ototoxic Hearing LossOtotoxicity, Drug-InducedCisplatin-induced Hearing Loss+8 more
Simon Jäger 55
Testing effectiveness (Phase 2)Looking for participantsNCT03480971
What this trial is testing

Treatment of Radiation and Cisplatin Induced Toxicities with Tempol

Who this might be right for
MucositisNephrotoxicityOtotoxicity
Matrix Biomed, Inc. 120
Large-scale testing (Phase 3)Study completedNCT01052844
What this trial is testing

Gabapentin in the Prevention of Nausea and Vomiting Induced by Chemotherapy

Who this might be right for
VomitingCisplatin Adverse Reaction
Faculdade de Medicina do ABC 80
Not applicableUnknownNCT05746598
What this trial is testing

Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Cisplatin Among Egyptian Non-small Cell Lung Cancer Patients

Who this might be right for
Non Small Cell Lung CancerNephropathyCardiotoxicity
Ain Shams University 178
Not applicableUnknownNCT00578760
What this trial is testing

Does Aspirin Have a Protective Role Against Chemotherapeutically Induced Ototoxicity?

Who this might be right for
Hearing LossOtotoxicity
University Health Network, Toronto 110
Large-scale testing (Phase 3)Study completedNCT04251689
What this trial is testing

The Effect of Intravenous Mannitol Plus Saline on the Prevention of Cisplatin-induced Nephrotoxicity: A Randomized, Double-blind, Placebo Controlled Trial

Who this might be right for
Cis-Platinum NephropathyMannitol Adverse Reaction
Phramongkutklao College of Medicine and Hospital 48
Not applicableUnknownNCT06019520
What this trial is testing

Role of N-Acetylcysteine for Prevention of Cisplatin-induced Nephrotoxicity

Who this might be right for
Drug Toxicity
Foundation University Islamabad 70
Testing effectiveness (Phase 2)UnknownNCT04351308
What this trial is testing

Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma

Who this might be right for
OsteosarcomaSurvivalChemotherapy Effect+1 more
Peking University People's Hospital 60
Early research (Phase 1)Study completedNCT04262336
What this trial is testing

Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment

Who this might be right for
Ototoxicity
Decibel Therapeutics 22
Large-scale testing (Phase 3)Study completedNCT00477607
What this trial is testing

Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin

Who this might be right for
OtotoxicityUnspecified Adult Solid Tumor
US Department of Veterans Affairs 39
Testing effectiveness (Phase 2)UnknownNCT00003251
What this trial is testing

Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganHead and Neck CancerRadiation Toxicity
University of Illinois at Chicago 46
Load More Results